查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
基因檢測服務市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按服務類型、疾病、服務提供者和地理位置
市場調查報告書
商品編碼
1424127

基因檢測服務市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按服務類型、疾病、服務提供者和地理位置

Genetic Testing Services Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type, Disease, Service Provider, and Geography
出版日期: | 出版商: The Insight Partners | 英文 193 Pages | 訂單完成後即時交付

價格

基因檢測服務市場規模預計將從2022年的34.25億美元成長到2030年的105.56億美元；預計2022-2030年CAGR為15.1%。

基因檢測服務市場的成長歸因於遺傳疾病的日益流行、對個人化藥物的認知和接受程度的提高以及對直接面對消費者的基因檢測的日益偏好。然而，基因檢測的社會和倫理影響以及基因服務的可負擔性阻礙了市場的成長。

中國、印度、墨西哥和巴西等新興國家為市場參與者提供了巨大的成長機會。高成長可歸因於公共醫療支出的增加、醫療基礎設施的改善以及目標患者群體的龐大。由於發展中經濟體對遺傳性疾病及其早期診斷的認知不斷提高，對基因檢測的需求也增加。

高收入國家和中低收入國家的遺傳服務品質和可得性可能有所不同。例如，遺傳服務在美國、澳洲、加拿大、英國和其他歐洲國家都很先進、成熟且廣泛。這些服務包括新生兒篩檢、攜帶者識別篩檢和產前診斷。然而，在許多高收入國家，在多種環境下提供的遺傳服務仍需要改進的評估系統。

基因檢測程序的簡單性和適用性使亞太地區和全球其他發展中地區的研發活動受益。主要市場參與者專注於策略和舉措，例如協議、合作、夥伴關係和擴張，以提高這些國家的產品可用性、可及性和分銷網路。這將有助於他們滿足日益成長的早期診斷和治療需求。例如，2019年，巴西領先的基因檢測實驗室之一GENOMIKA與Veritas達成協議，將全基因組定序以及與預防醫學和臨床遺傳學這些檢測相關的所有服務涵蓋其產品組合。

中國政府將基因組學確定為經濟社會發展第十四個五年規​​劃（2016-2020）的重要策略領域。 2016年，中國科學院啟動了精準醫學計劃，這是一個為期14年、價值92億美元的項目，目標是到2030年對超過1億個人類基因組進行測序。2017年12月，中國科技部與人類基因組合作記錄 10 萬人基因組成的研究計畫。研究人員希望利用九個不同少數群體的遺傳資料來解碼基因內的遺傳訊息。此外，發展中經濟體消費者對 DTC 基因檢測的認知不斷提高，為 DTC 產業提供了成長機會。

因此，預計發展中國家的新興市場將為市場參與者提供重大成長機會，並在預測期內促進市場成長。

截至 2018 年，市場上已有約 75,000 種基因檢測產品，每天有近 10 種新檢測產品進入市場。根據 2023 年發表的研究《2012-2022 年美國基因檢測可用性趨勢》，美國和全球分別有約 129,624 項和 197,779 項基因檢測已可供使用並提交給基因檢測登記處截至2022 年11 月。這些測試已從單基因測試擴展到觀察多個基因的面板。為了解決日益嚴重的健康資料耗盡問題，醫學領域擴大圍繞著增強的臨床工具，例如人工智慧（AI）和機器學習，這些工具被認為是提高基因組醫學接受度的一種方法。如今，許多公司已轉向機器學習來處理正確分析和理解放射學和心臟病學等領域的臨床資料所需的大量資料。

市場上許多面向消費者的基因檢測技術都使用機器學習或人工智慧來發揮作用。從很多方面來說，疾病基因檢測都是機器學習的完美領域，因為這些程式需要處理大量資料。例如，研究人類基因組包括讀取數十億位元訊息，而在引入機器學習之前，其中許多任務都非常棘手。人工智慧在分析遺傳資料和支援臨床專家診斷方面具有巨大潛力。

谷歌有一個名為 Deep Variant 的程序，現在可以用來徹底繪製人類基因組圖，並可以用於一個人的全部遺傳資訊。此外，美國國立衛生研究院等機構正在研究機器學習和人工智慧如何幫助人們更好地理解遺傳學和基因組學。因此，透過成功整合這些工具，臨床醫生將能夠更有效率地診斷罕見遺傳疾病。

基於服務提供者的見解

根據服務提供者，基因檢測服務市場分為一般檢測服務和基於液體活體組織切片的 CGP、MRD 和 MCED 服務。 2022年，通用測試服務領域佔最大市場佔有率，預計2022-2023年複合CAGR最高。遺傳和分子檢測對於檢測許多遺傳性疾病、與遺傳相關的軀體或後天性疾病以及藥物遺傳學反應至關重要。多種基因測試可用於分析遺傳、染色體或蛋白質修飾。在選擇合適的測試時，醫療保健提供者會考慮幾個因素，包括疑似病症和通常與之相關的遺傳變異。市面上可用的幾種類型的基因測試是基於分子、染色體和生化機制以及基因表現等。

一般基因檢測是對頭髮、皮膚、血液、羊水（懷孕期間胎兒周圍的液體）或其他組織樣本進行的。 COVID-19 PCR 測試使用與病毒遺傳物質片段匹配的引物，可以擴增從樣本中提取的遺傳物質，以檢測病毒的存在。

疾病管制與預防中心、美國食品藥物管理局以及世界衛生組織是準備基因檢測服務市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：基因檢測服務市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：基因檢測服務市場 - 主要產業動態

  • 主要市場促進因素
    • 遺傳性疾病盛行率上升
    • 提高對個人化藥物的認知和接受度
    • 對直接面對消費者 (DTC) 的基因檢測的偏好日益成長
  • 市場限制
    • 基因檢測的社會和倫理影響
    • 遺傳服務的承受能力
  • 市場機會
    • 發展中國家尚未開發的新興市場
  • 未來的趨勢
    • 人工智慧驅動的基因檢測
  • 影響分析：

第 6 章：基因檢測服務市場 - 全球市場分析

  • 基因檢測服務市場收入，2022 - 2030

第 7 章：全球基因檢測服務市場 - 收入和 2030 年預測 - 按服務類型

  • 概述
  • 2022 年及 2030 年基因檢測服務市場收入佔有率（按服務類型分類）（%）
  • 預測測試
  • 營運商測試
  • 產前檢測
  • 新生兒篩檢
  • 診斷基因檢測
  • 其他

第 8 章：全球基因檢測服務市場 - 收入和 2030 年預測 - 按疾病分類

  • 概述
  • 2022 年和 2030 年按疾病分類的基因檢測服務市場收入佔有率 (%)
  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 其他疾病

第 9 章：全球基因檢測服務市場 - 收入和 2030 年預測 - 按服務提供者

  • 概述
  • 2022 年和 2030 年基因檢測服務市場收入佔有率（按服務提供者分類）（%）
  • 通用測試服務
  • 基於液體活體組織切片的 CGP、MRD 和 MCED 服務

第 10 章：基因檢測服務市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：基因檢測服務市場-產業格局

  • 概述
  • 基因檢測服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG
  • Bio-Rad Laboratories Inc

第 13 章：附錄

Product Code: TIPHE100001383

The genetic testing services market size is expected to grow from US$ 3.425 billion in 2022 to US$ 10.556 billion by 2030; it is estimated to record a CAGR of 15.1% during 2022-2030.

The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.

Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.

The quality and availability of genetic services may differ between high-income and low- to middle-income countries. For instance, genetic services are well-advanced, established, and extensive in the US, Australia, Canada, the UK, and other European countries. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services offered in multiple settings still need improved assessment systems.

The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players focus on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries. This will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of Brazil's leading genetic testing laboratories, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in preventive medicine and clinical genetics into its portfolio.

The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016-2020) for economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.

Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.

As of 2018, there were ~75,000 genetic tests available in the market, with nearly 10 new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012-2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to analyze and understand clinical data correctly in fields such as radiology and cardiology.

Many of the consumer-facing genetic testing technologies available in the market use machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and many of these tasks were pretty tricky before the introduction of machine learning. AI offers great potential in analyzing genetic data and supporting clinical specialists in diagnosing.

Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways machine learning and AI can add to a better understanding of genetics and genomics. Thus, by successfully integrating these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.

Service Provider -Based Insights

Based on the service provider, the genetic testing services market is segmented into general testing services and liquid biopsy-based CGP, MRD, and MCED services. In 2022, the general testing services segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2023. Genetic and molecular testing is fundamental for detecting many inherited disorders, somatic or acquired diseases with genetic associations, and pharmacogenetic responses. Multiple genetic tests are available to analyze genetic, chromosomal, or protein modifications. When selecting the suitable test, a healthcare provider considers several factors, including suspected conditions and genetic variations typically associated with them. Several types of genetic tests available in the market are based on molecular, chromosomal, and biochemical mechanisms, as well as gene expressions, among others.

General genetic tests are performed on hair, skin, blood, amniotic fluid (the fluid surrounding a fetus during pregnancy), or other tissue samples. COVID-19 PCR tests use primers matching a virus's genetic material segment, allowing the amplification of the genetic material extracted from samples to detect the presence of the virus.

Centers for Disease Control and Prevention, the US Food and Drug Administration, and the World Health Organization are among the primary and secondary sources referred to while preparing the genetic testing services market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the genetic testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Genetic Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Genetic Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Genetic Diseases
    • 5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 Social and Ethical Implications of Genetic Testing
    • 5.2.2 Affordability of Genetic Services
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Artificial Intelligence-Powered Genetic Testing
  • 5.5 Impact Analysis:

6. Genetic Testing Services Market - Global Market Analysis

  • 6.1 Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 7.1 Overview
  • 7.2 Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 7.3 Predictive Testing
    • 7.3.1 Overview
    • 7.3.2 Predictive Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Carrier Testing
    • 7.4.1 Overview
    • 7.4.2 Carrier Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Prenatal Testing
    • 7.5.1 Overview
    • 7.5.2 Prenatal Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Newborn Screening
    • 7.6.1 Overview
    • 7.6.2 Newborn Screening: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Diagnostic Genetic Testing
    • 7.7.1 Overview
    • 7.7.2 Diagnostic Genetic Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 8.1 Overview
  • 8.2 Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 8.3 Cancer
    • 8.3.1 Overview
    • 8.3.2 Cancer: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Overview
    • 8.4.2 Cardiovascular Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Metabolic Diseases
    • 8.5.1 Overview
    • 8.5.2 Metabolic Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Diseases
    • 8.6.1 Overview
    • 8.6.2 Other Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 9.1 Overview
  • 9.2 Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 9.3 General Testing Service
    • 9.3.1 Overview
    • 9.3.2 General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.1 Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.2 Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.3 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Liquid biopsy-based CGP, MRD, and MCED Service
    • 9.4.1 Overview
    • 9.4.2 Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.2 Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.3 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Genetic Testing Services Market - Geographical Analysis

  • 10.1 North America Genetic Testing Services Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.1.4 North America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.1.5 North America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.5.1 North America: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.5.2 North America: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.1.6 North America Genetic Testing Services Market, by Country
      • 10.1.6.1 US
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.1.3 US: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.1.4 US: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.1.5 US: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.6.2 Canada
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.2.3 Canada: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.2.4 Canada: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.2.5 Canada: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.6.3 Mexico
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.3.3 Mexico: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.3.4 Mexico: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.3.5 Mexico: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.2 Europe Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.5.1 Europe: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.5.2 Europe: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.2.6 Europe Genetic Testing Services Market, by Country
      • 10.2.6.1 UK
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.1.3 UK: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.1.4 UK: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.1.5 UK: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.2 Germany
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.2.3 Germany: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.2.4 Germany: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.2.5 Germany: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.3 France
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.3.3 France: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.3.4 France: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.3.5 France: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.4.3 Italy: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.4.5 Italy: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.5.3 Spain: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.5.5 Spain: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.6.3 Rest of Europe: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.5.1 Asia Pacific: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.5.2 Asia Pacific: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific Genetic Testing Services Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.1.3 China: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.1.5 China: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.2.3 Japan: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.2.5 Japan: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.3 India
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.3.3 India: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.3.5 India: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.4.3 Australia: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.4.5 Australia: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.5.3 South Korea: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.5.5 South Korea: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.6.3 Rest of Asia Pacific: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.5.1 Middle East & Africa: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.5.2 Middle East & Africa: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.4.6 Middle East & Africa Genetic Testing Services Market, by Country
      • 10.4.6.1 Saudi Arabia
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.1.3 Saudi Arabia: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.1.5 Saudi Arabia: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.2 UAE
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.2.3 UAE: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.2.4 UAE: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.2.5 UAE: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.3 South Africa
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.3.3 South Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.3.4 South Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.3.5 South Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.4.3 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.5 South & Central America Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.5.1 South & Central America: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.5.2 South & Central America: Liquid biopsy-based CGP, MRD, and MCED Services, by Service Provider, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America Genetic Testing Services Market, by Country
      • 10.5.6.1 Brazil
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.1.3 Brazil: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.1.4 Brazil: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.1.5 Brazil: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.6.2 Argentina
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.2.3 Argentina: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.2.4 Argentina: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.2.5 Argentina: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.6.3 Rest of South & Central America
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.3.3 Rest of South & Central America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.3.5 Rest of South & Central America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

11. Genetic Testing Services Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Genetic Testing Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eurofins Scientific SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Exact Sciences Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Laboratory Corp of America Holdings
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4andMe Holding Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ambry Genetics Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Quest Diagnostics Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Illumina Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 F. Hoffmann-La Roche Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 NeoGenomics Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Centogene AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Bio-Rad Laboratories Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Genetic Testing Services Market Segmentation
  • Table 2. North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America General Testing Service Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe General Testing Service Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. UK Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. UK Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. UK Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Germany Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. France Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Italy Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Italy Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Italy Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Spain Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Spain Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Spain Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Asia Pacific Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Asia Pacific Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. China Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. China Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. China Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Japan Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Japan Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Japan Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. India Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. India Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. India Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Australia Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Australia Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Australia Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. South Korea Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. South Korea Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. South Korea Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Rest of Asia Pacific Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Rest of Asia Pacific Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Rest of Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Middle East & Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Middle East & Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Saudi Arabia Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Saudi Arabia Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Saudi Arabia Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. UAE Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. UAE Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. UAE Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. South Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. South Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. South Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Rest of Middle East & Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Rest of Middle East & Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Rest of Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Brazil Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Brazil Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Brazil Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Argentina Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. Argentina Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Argentina Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 94. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 95. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Genetic Testing Services Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Genetic Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Genetic Testing Services Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 8. Predictive Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Prenatal Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Newborn Screening: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Diagnostic Genetic Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 15. Cancer: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cardiovascular Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Metabolic Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 20. General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America: Genetic Testing Services Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. North America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Europe Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 35. Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Europe Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 37. UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Asia Pacific Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 44. Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Asia Pacific Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 46. China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Middle East & Africa Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 53. Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Middle East & Africa Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 55. Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. South & Central America Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 60. South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. South & Central America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 62. Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 63. Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Growth Strategies in Genetic Testing Services Market